Professor, Internal Medicine, Yale University School of Medicine
Cardiology
Dr. Harlan M. Krumholz, MD
|
|
Give Review
Harlan M. Krumholz, MD is an expert in the field of Cardiology. He went to Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School is ranked 1 in research and 12 in primary care medicine He has 3 awards "Elected Member", "Fellow (FACC)" and "Whos Who in Medicine and Healthcare". Dr. Harlan M. Krumholz is a published doctor and has 101 publications published. The lastest was: 'Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes.'
Publications
- Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes.
- Vena Caval Filter Utilization and Outcomes in Pulmonary Embolism: Medicare Hospitalizations From 1999 to 2010.
- Association of Admission to Veterans Affairs Hospitals vs Non-Veterans Affairs Hospitals With Mortality and Readmission Rates Among Older Men Hospitalized With Acute M...
- Return to Work After Acute Myocardial Infarction: Comparison Between Young Women and Men.
- Organizational culture change in U.S. hospitals: a mixed methods longitudinal intervention study.
- Sex Differences in Cardiac Risk Factors, Perceived Risk, and Health Care Provider Discussion of Risk and Risk Modification Among Young Patients With Acute Myocardial I...
- Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary Intervention.
- Patterns of Institutional Review of Percutaneous Coronary Intervention Appropriateness and the Effect on Quality of Care and Clinical Outcomes.
- National Trends in Pulmonary Embolism Hospitalization Rates and Outcomes for Adults Aged ≥65 Years in the United States (1999 to 2010).
- Regulatory watch: Characterizing the US FDA's approach to promoting transformative innovation.
- Insurance and Prehospital Delay in Patients ≤55 Years With Acute Myocardial Infarction.
- Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2...
- Mortality, Hospitalizations, and Expenditures for the Medicare Population Aged 65 Years or Older, 1999-2013.
- Women in clinical research: what we need for progress.
- Poorly Cited Articles in Peer-Reviewed Cardiovascular Journals from 1997-2007: Analysis of 5-Year Citation Rates.
- Gender differences in pre-event health status of young patients with acute myocardial infarction: A VIRGO study analysis.
- Risk after hospitalization: we have a lot to learn.
- Intravenous fluids in acute decompensated Heart failure.
- Trends in Hospitalizations Among Medicare Survivors of Aortic Valve Replacement in the United States From 1999 to 2010.
- Hospital Strategy Uptake and Reductions in Unplanned Readmission Rates for Patients with Heart Failure: A Prospective Study.
- Sexual activity and counseling in the first month after acute myocardial infarction among younger adults in the United States and Spain: a prospective, observational s...
- STEMI care in LMIC: obstacles and opportunities.
- Payments for Acute Myocardial Infarction Episodes-of-Care Initiated at Hospitals With and Without Interventional Capabilities.
- Managing the information boundary of an organization: key aspect of translating research into practice.
- Relation between door-to-balloon times and mortality after primary percutaneous Coronary intervention over time: a retrospective study.
- Readmission rates and long-term hospital costs among survivors of an in-hospital cardiac arrest.
- Trends in Aortic Dissection Hospitalizations, Interventions, and Outcomes Among Medicare Beneficiaries in the United States, 2000-2011.
- Addressing the trauma of hospitalization--reply.
- Place of residence and outcomes of patients with Heart failure: analysis from the telemonitoring to improve Heart failure outcomes trial.
- Readmissions after hospitalization for Heart failure, acute myocardial infarction, or pneumonia among young and middle-aged adults: a retrospective observational cohor...
- Trends in Use of Ezetimibe After the ENHANCE Trial, 2007 Through 2010.
- Open access to clinical trials data.
- Hospital Cardiovascular Outcome Measures in Federal Pay-for-Reporting and Pay-for-Performance Programs: A Brief Overview of Current Efforts.
- Big data and new knowledge in medicine: the thinking, training, and tools needed for a learning health system.
- Impact of Drug Policy on Regional Trends in Ezetimibe Use.
- National Patterns of Risk-Standardized Mortality and Readmission After Hospitalization for Acute Myocardial Infarction, Heart Failure, and Pneumonia: Update on Publicl...
- National Trends in US Hospital Admissions for Hyperglycemia and Hypoglycemia Among Medicare Beneficiaries, 1999 to 2011.
- Descriptions and Interpretations of the ACCORD-Lipid Trial in the News and Biomedical Literature: A Cross-Sectional Analysis.
- Role of nicotinic Acid in atherosclerosis prevention-reply.
- Variation in hospital-level risk-standardized complication rates following elective primary total hip and knee arthroplasty.
- Strategies to reduce Heart failure readmissions.
- Reporting of results in ClinicalTrials.gov and high-impact journals.
- Caution Warranted When Defining Contraindications in Initiating β-Blocker Therapy-Reply.
- Hospital Variation in the Use of Noninvasive Cardiac Imaging and Its Association With Downstream Testing, Interventions, and Outcomes.
- Usual Source of Care and Outcomes Following Acute Myocardial Infarction.
- Transfer rates from nonprocedure hospitals after initial admission and outcomes among elderly patients with acute myocardial infarction.
- Moving Forward from rhBMP-2: Open Science and Data Sharing.
- Hospital Variation in Intravenous Inotrope Use for Patients Hospitalized with Heart Failure: Insights from Get With The Guidelines.
- National trends in patient safety for four common conditions, 2005-2011.
- Comparing Diabetes Medications: Where Do We Set the Bar?
- Urinary Biomarkers of AKI and Mortality 3 Years after Cardiac Surgery.
- Response to letters regarding article, "comparison of clinical interpretation with visual assessment and quantitative Coronary angiography in patients undergoing percu...
- Determinants of fluoroscopy time for invasive Coronary angiography and percutaneous Coronary intervention: Insights from the NCDR(®).
- National trends in Heart failure hospitalization after acute myocardial infarction for medicare beneficiaries: 1998-2010.
- Impact of coronary artery calcium on coronary heart Disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosc...
- Contemporary Data About Hospital Strategies to Reduce Unplanned Readmissions: What Has Changed?
- Contraindicated Initiation of β-Blocker Therapy in Patients Hospitalized for Heart Failure.
- Quality collaboratives and campaigns to reduce readmissions: What strategies are hospitals using?
- The case for generic statins: not if they don't work so well-reply.
- Quality of Discharge Practices and Patient Understanding at an Academic Medical Center.
- Patterns of change in nesiritide use in patients with Heart failure: how hospitals react to new information.
- Prevalence of Traditional Cardiac Risk Factors and Secondary Prevention Among Patients Hospitalized for Acute Myocardial Infarction (AMI): Variation by Age, Sex, and R...
- Use of niacin in the United States and Canada.
- A High Risk of Hospitalization Following Release From Correctional Facilities in Medicare Beneficiaries: A Retrospective Matched Cohort Study, 2002 to 2010.
- HbA1c and Risk of Severe Hypoglycemia in Type 2 Diabetes: The Diabetes and Aging Study.
- Decision-making preferences among patients with an acute myocardial infarction.
- Spending more, doing more, or both? An alternative method for quantifying utilization during hospitalizations.
- Hospital-Based, Acute Care Use Among Patients Within 30 Days of Discharge After Coronary Artery Bypass Surgery.
- Statins: Is It Safe and Effective to Use Generic "Equivalents"?
- Dominance of furosemide for loop diuretic therapy in Heart failure: time to revisit the alternatives?
- Ushering in a new era of open science through data sharing: the wall must come down.
- Long-term outcomes in elderly survivors of in-hospital cardiac arrest.
- National trends in Heart failure hospital stay rates, 2001 to 2009.
- Comprehensive quality of discharge summaries at an academic medical center.
- Comparison of Clinical Interpretation with Visual Assessment and Quantitative Coronary Angiography in Patients Undergoing Percutaneous Coronary Intervention in Contemp...
- Income inequality and 30 day outcomes after acute myocardial infarction, Heart failure, and pneumonia: retrospective cohort study.
- Risk factors for hospital admission among older persons with newly diagnosed Heart failure: findings from the cardiovascular health study.
- Variation exists in rates of admission to intensive care units for Heart failure patients across hospitals in the United States.
- Hospital collaboration with emergency medical services in the care of patients with acute myocardial infarction: perspectives from key hospital staff.
- When choosing statin therapy: the case for generics.
- Measuring hospital clinical outcomes.
- Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, Heart failure, or pneumonia.
- Tamiflu: 14 flu seasons and still questions.
- Parental Immigration Status is Associated with Children's Health Care Utilization: Findings from the 2003 New Immigrant Survey of US Legal Permanent Residents.
- Diagnoses and timing of 30-day readmissions after hospitalization for Heart failure, acute myocardial infarction, or pneumonia.
- Post-hospital syndrome--an acquired, transient condition of generalized risk.
- Features of High Quality Discharge Planning for Patients Following Acute Myocardial Infarction.
- Hospital patterns of use of positive inotropic agents in patients with Heart failure.
- Correlations among risk-standardized mortality rates and among risk-standardized readmission rates within hospitals.
- Contemporary Evidence about Hospital Strategies for Reducing 30-Day Readmissions: A National Study.
- Regulatory review of novel therapeutics--comparison of three regulatory agencies.
- Hospital strategies for reducing risk-standardized mortality rates in acute myocardial infarction.
- Building hospital management capacity to improve patient flow for cardiac catheterization at a cardiovascular hospital in Egypt.
- Comparison of hospital risk-standardized mortality rates calculated by using in-hospital and 30-day models: an observational study with implications for hospital profi...
- Three Reasons to Abandon Low-Density Lipoprotein Targets: An Open Letter to the Adult Treatment Panel IV of the National Institutes of Health.
- State Medicaid programs did not make use of prior authorization to promote safer prescribing after rosiglitazone warning.
- Skilled nursing facility referral and hospital readmission rates after Heart failure or myocardial infarction.
- Generic Atorvastatin and Health Care Costs.
- Use and Effectiveness of Intra-Aortic Balloon Pumps Among Patients Undergoing High Risk Percutaneous Coronary Intervention: Insights From the National Cardiovascular D...
- US Cardiologist Workforce From 1995 To 2007: Modest Growth, Lasting Geographic Maldistribution Especially In Rural Areas.
Schools
Harvard Medical School
Beth Israel Hospital
Procedures Preformed
- Cardiac Imaging
- Cardioversion, Elective
Conditions Treated
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- Cardiomyopathy
- Congestive Heart Failure
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Pathway X Ind PPO Direct Access CT
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Connecticare HMO
- Connecticare POS
- Humana
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Freedom Plan
- Priority Health
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
- United Healthcare
Awards
- Elected Member
- Fellow (FACC)
- Whos Who in Medicine and Healthcare
Education
-
Beth Israel Deaconess Medical Center -
UCSF -
Harvard Medical School
Hospital
-
Yale-New Haven Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Marcos Amuchastegui, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James H. Revkin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Simons, MD |
|
|
Dr. Daniel Jacoby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andre E. Ghantous, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bennett Cua, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Craig A. McPherson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chileshe N. Nkonde, MD |
|
|
Dr. David J. Hur, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles J. Rouse, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sara Seidelmann, MD |
|
|
Lester G. Joseph |